Document and Entity Information
Document and Entity Information | Aug. 27, 2025 |
Cover [Abstract] | |
Amendment Flag | false |
Entity Central Index Key | 0001175505 |
Document Type | 8-K |
Document Period End Date | Aug. 27, 2020 |
Entity Registrant Name | Five Prime Therapeutics, Inc. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-36070 |
Entity Tax Identification Number | 26-0038620 |
Entity Address, Address Line One | 111 Oyster Point Boulevard |
Entity Address, City or Town | South San Francisco |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94080 |
City Area Code | (415) |
Local Phone Number | 365-5600 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, par value $0.001 per share |
Trading Symbol | FPRX |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |